Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
17 05 2022
Historique:
received: 31 03 2022
revised: 12 05 2022
accepted: 14 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

ZED1227 is a small molecule tissue transglutaminase (TG2) inhibitor. The compound selectively binds to the active state of TG2, forming a stable covalent bond with the cysteine in its catalytic center. The molecule was designed for the treatment of celiac disease. Celiac disease is an autoimmune-mediated chronic inflammatory condition of the small intestine affecting about 1-2% of people in Caucasian populations. The autoimmune disease is triggered by dietary gluten. Consumption of staple foods containing wheat, barley, or rye leads to destruction of the small intestinal mucosa in genetically susceptible individuals, and this is accompanied by the generation of characteristic TG2 autoantibodies. TG2 plays a causative role in the pathogenesis of celiac disease. Upon activation by Ca

Identifiants

pubmed: 35626704
pii: cells11101667
doi: 10.3390/cells11101667
pmc: PMC9139979
pii:
doi:

Substances chimiques

Imidazoles 0
Peptides 0
Pyridines 0
ZED1227 0
Glutens 8002-80-0
Gliadin 9007-90-3
Protein Glutamine gamma Glutamyltransferase 2 EC 2.3.2.13
Transglutaminases EC 2.3.2.13
GTP-Binding Proteins EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Protein Sci. 1994 Jul;3(7):1131-5
pubmed: 7920263
Nat Rev Dis Primers. 2019 Jan 10;5(1):3
pubmed: 30631077
Nat Med. 1998 Jun;4(6):666-7
pubmed: 9623970
Cancer Chemother Pharmacol. 1988;21(1):78-84
pubmed: 3342470
Chem Biol. 2003 Mar;10(3):225-31
pubmed: 12670536
AAPS J. 2010 Sep;12(3):397-406
pubmed: 20458565
Drug Discov Today. 2018 Mar;23(3):575-591
pubmed: 29362136
Science. 2002 Sep 27;297(5590):2275-9
pubmed: 12351792
Org Biomol Chem. 2018 Mar 28;16(12):2006-2027
pubmed: 29479624
Acta Paediatr (Stockh). 1953 May;42(3):223-31
pubmed: 13079757
Mini Rev Med Chem. 2007 Oct;7(10):1040-50
pubmed: 17979807
Nutr Clin Pract. 2006 Feb;21(1):1-15
pubmed: 16439765
Anal Biochem. 2020 Apr 15;595:113612
pubmed: 32045569
Biochim Biophys Acta. 1957 Aug;25(2):451-2
pubmed: 13471608
Biochem J. 1997 Jun 15;324 ( Pt 3):797-805
pubmed: 9210403
J Biol Chem. 2004 Apr 23;279(17):17607-16
pubmed: 14747475
Mol Cell Biol. 2001 Jan;21(1):148-55
pubmed: 11113189
PLoS Biol. 2007 Dec;5(12):e327
pubmed: 18092889
Gastroenterology. 2012 Sep;143(3):698-707.e4
pubmed: 22750506
J Thromb Haemost. 2020 Jan;18(1):191-200
pubmed: 31578814
Future Med Chem. 2021 Jan;13(2):193-210
pubmed: 33275063
Nat Rev Drug Discov. 2011 Apr;10(4):307-17
pubmed: 21455239
Biochemistry. 1994 Aug 23;33(33):10109-19
pubmed: 7914744
J Med Chem. 2003 Jan 2;46(1):49-63
pubmed: 12502359
Blood. 1990 Apr 1;75(7):1455-9
pubmed: 1969293
J Immunol. 2015 Dec 1;195(11):5159-68
pubmed: 26503953
J Proteome Res. 2005 Sep-Oct;4(5):1732-41
pubmed: 16212427
Science. 2020 Apr 24;368(6489):409-412
pubmed: 32198291
J Am Chem Soc. 2021 Jul 21;143(28):10537-10540
pubmed: 34232639
Ann N Y Acad Sci. 1981;370:836-42
pubmed: 6115611
Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):181-195
pubmed: 33219355
FASEB J. 2019 Jan;33(1):3-12
pubmed: 30593123
J Cell Sci. 2015 Dec 15;128(24):4615-28
pubmed: 26542019
J Biol Chem. 2002 Sep 13;277(37):34109-16
pubmed: 12093810
Anal Biochem. 1971 Nov;44(1):221-31
pubmed: 5132838
Comb Chem High Throughput Screen. 2016;19(6):461-9
pubmed: 27137915
Clin Sci (Lond). 1985 May;68(5):573-9
pubmed: 2858282
Amino Acids. 2003 Apr;24(3):231-43
pubmed: 12707805
Immunogenetics. 2017 Aug;69(8-9):605-616
pubmed: 28695286
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11000-7
pubmed: 10500114
N Engl J Med. 2021 Jul 1;385(1):35-45
pubmed: 34192430
J Biol Chem. 2010 Aug 13;285(33):25402-9
pubmed: 20547769
Nat Med. 1997 Jul;3(7):797-801
pubmed: 9212111
Scand J Immunol. 1998 Aug;48(2):111-5
pubmed: 9716100
Gastroenterology. 2020 Aug;159(2):788-790
pubmed: 32302613
Gut. 1997 Dec;41(6):851-2
pubmed: 9462222
Nat Med. 1998 Jun;4(6):713-7
pubmed: 9623982
Hum Immunol. 2012 Apr;73(4):376-81
pubmed: 22342873
Eur J Pharm Sci. 2010 Nov 20;41(3-4):452-7
pubmed: 20656026
J Immunol. 2004 Aug 1;173(3):1757-62
pubmed: 15265905
J Biol Chem. 2011 Oct 28;286(43):37866-73
pubmed: 21908620
Biomedicine (Taipei). 2017 Sep;7(3):15
pubmed: 28840829
PLoS One. 2015 Aug 05;10(8):e0134922
pubmed: 26244572

Auteurs

Christian Büchold (C)

Zedira GmbH, Roesslerstrasse 83, 64293 Darmstadt, Germany.

Martin Hils (M)

Zedira GmbH, Roesslerstrasse 83, 64293 Darmstadt, Germany.

Uwe Gerlach (U)

Sanofi-Aventis Deutschland GmbH, UG Serves as External Consultant for Medicinal Chemistry to Zedira, 65926 Frankfurt, Germany.

Johannes Weber (J)

Zedira GmbH, Roesslerstrasse 83, 64293 Darmstadt, Germany.

Christiane Pelzer (C)

Zedira GmbH, Roesslerstrasse 83, 64293 Darmstadt, Germany.

Andreas Heil (A)

Zedira GmbH, Roesslerstrasse 83, 64293 Darmstadt, Germany.

Daniel Aeschlimann (D)

Matrix Biology & Tissue Repair Research Unit, School of Dentistry, Cardiff University, Heath Park, Cardiff CF14 4XY, Wales, UK.

Ralf Pasternack (R)

Zedira GmbH, Roesslerstrasse 83, 64293 Darmstadt, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH